IP Library › Granted Patent US 11,793,196
Granted Patent B2
US 11,793,196 · App. 16/822,279 · Granted Oct 24, 2023

Fusion proteins, recombinant bacteria, and exosporium fragments for pest control and plant health

Inventors: Damian Curtis (Davis, CA); Kevin Bugg (Apex, NC)
Assignee: Bayer CropScience LP
A01N37/46C07K14/32C12N9/6424C07K2319/00C07K2319/035
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,793,196
App. No.
16/822,279
Granted
Oct 24, 2023
Kind
B2
Abstract

The present invention relates to a fusion protein having a targeting sequence, exosporium protein, or exosporium protein fragment that targets the fusion protein to the exosporium of a recombinant Bacillus cereus family member and an enzyme having serine protease activity, wherein the enzyme having serine protease activity is from Bacillus firmus or is a variant of such enzyme. The present invention also provides a recombinant Bacillus cereus family member that expresses such fusion protein and exosporium fragments derived from such recombinant Bacillus cereus family member. Methods of using such recombinant Bacillus cereus family members or exosporium fragments derived therefrom for nematode control are also provided.

Claims (46)

1. A fusion protein comprising:

a targeting sequence, exosporium protein, or exosporium protein fragment that targets the fusion protein to the exosporium of a recombinant Bacillus cereus family member; and

an enzyme having serine protease activity, wherein the enzyme

comprises or consists of SEQ ID NO: 211 or SEQ ID NO: 212;

or a combination of any thereof.

2. The fusion protein of claim 1 , wherein the targeting sequence comprises or consists of:

(a) an amino acid sequence having at least about 43% identity with amino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids 25-35 is at least about 54%;

(b) amino acids 1-35 of SEQ ID NO: 1;

(c) amino acids 20-35 of SEQ ID NO: 1;

(d) SEQ ID NO: 1;

(e) SEQ ID NO: 96; or

(f) SEQ ID NO: 120.

3. The fusion protein of claim 1 , wherein the targeting sequence comprises the sequence X 1 -X 2 -X 3 -X 4 -X 5 -X 6 -X 7 -X 8 -X 9 -X 10 -X 11 -X 12 -X 13 -X 14 -X 15 -X 16 , wherein:

X 1 is any amino acid or absent;

X 2 is phenylalanine (F), leucine (L), isoleucine (I), or methionine (M);

X 3 is any amino acid;

X 4 is proline (P) or serine (S);

X 5 is any amino acid;

X 6 is leucine (L), asparagine (N), serine (S), or isoleucine (I);

X 7 is valine (V) or isoleucine (I);

X 8 is glycine (G);

X 9 is proline (P);

X 10 is threonine (T) or proline (P);

X 11 is leucine (L) or phenylalanine (F);

X 12 is proline (P);

X 13 is any amino acid;

X 14 is any amino acid;

X 15 is proline (P), glutamine (Q), or threonine (T); and

X 16 is proline (P), threonine (T), or serine (S).

4. The fusion protein of claim 2 , wherein the targeting sequence, exosporium protein, or exosporium protein fragment further comprises a methionine, serine, or threonine residue at the amino acid position immediately preceding the first amino acid of the targeting sequence, exosporium protein, or exosporium protein fragment or at the position of the targeting sequence that corresponds to amino acid 20 of SEQ ID NO: 1.

5. The fusion protein of claim 1 , wherein the fusion protein further comprises an amino acid linker between the targeting sequence, the exosporium protein, or the exosporium protein fragment and the enzyme having serine protease activity.

6. A recombinant Bacillus cereus family member that expresses a fusion protein of claim 1 .

7. The recombinant Bacillus cereus family member of claim 6 , wherein the recombinant Bacillus cereus family member comprises a mutation that results in the Bacillus cereus family member spores having an exosporium that is easier to remove from the spore as compared to the exosporium of a wild-type spore.

8. The recombinant Bacillus cereus family member of claim 7 , wherein the recombinant Bacillus cereus family member comprises:

(i) a mutation in a CotE gene;

(ii) a mutation in an ExsY gene;

(iii) a mutation in a CotY gene;

(iv) a mutation in a ExsA gene;

(v) a mutation in a CotO gene.

9. A fermentation product of the recombinant Bacilus cereus family member claim 6 .

10. Exosporium fragments derived from the recombinant Bacillus cereus family member of claim 7 , wherein the exosporium fragments comprise or consist of SEQ ID NO: 211 or SEQ ID NO: 212.

11. A formulation comprising the fermentation product of claim 9 and an agriculturally acceptable carrier.

12. A formulation comprising the exosporium fragments of claim 10 and an agriculturally acceptable carrier.

13. A plant seed treated with the formulation of claim 11 or claim 12 .

14. A method for stimulating plant growth and/or promoting plant health and/or controlling nematodes, comprising applying a recombinant Bacillus cereus family member of claim 6 to a plant growth medium, a plant, a plant seed, or an area surrounding a plant or a plant seed.

15. A method for stimulating plant growth and/or promoting plant health and/or controlling nematodes, comprising applying exosporium fragments of claim 7 to a plant growth medium, a plant, a plant seed, or an area surrounding a plant or a plant seed.

Assignments (2)
CHANGE OF NAME Recorded Feb 5, 2026
From: BAYER CROPSCIENCE LP
To: BAYER CROPSCIENCE LLC
Reel/Frame 074721/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2020
From: CURTIS, DAMIAN; BUGG, KEVIN
To: BAYER CROPSCIENCE LP
Reel/Frame 052163/0928 →
Continuity (2)
Provisional Application 62820773 · Mar 19, 2019
Related Publication 20200296960A1 · Sep 24, 2020
Cited By (1)
US 12,527,323